BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Newcastle Hospitals Clinical Skills Academy - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://skillsacademy.newcastle-hospitals.nhs.uk
X-WR-CALDESC:Events for Newcastle Hospitals Clinical Skills Academy
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20241022T093000
DTEND;TZID=Europe/London:20241022T123000
DTSTAMP:20260420T230858
CREATED:20240614T130156Z
LAST-MODIFIED:20250429T143126Z
UID:10000080-1729589400-1729600200@skillsacademy.newcastle-hospitals.nhs.uk
SUMMARY:Beginner's Guide to Cancer Immunotherapy - October 2024
DESCRIPTION:This course will introduce the science behind many forms of immunotherapy\, including immune checkpoint inhibitors\, treatment vaccines\, and CAR T cells. \nOverview\nAn introduction to immunotherapy: what it is\, how it works\, and who it’s given to. \nDuring this half day course Dr Elaine Vickers – a leading independent educator on the science of new cancer treatments – will introduce the science behind modern cancer immunotherapies for solid tumours and haematological cancers. \nThe course begins with an introduction to the relationship between cancer and the immune system. This relationship evolves with time\, and Elaine will describe how cancer cells evade and suppress white blood cells to stay alive. \nShe then explains how immune checkpoint inhibitors such as nivolumab and pembrolizumab hope to boost the cancer-fighting response from the person’s immune system. To do this\, she’ll discuss some of the critical features of T lymphocytes and why they’re the focus of these treatments. \nFinally\, in the third session of the morning\, Elaine will describe many other forms of immunotherapy given to cancer patients. These include treatment vaccines\, oncolytic viruses\, double-ended proteins called T cell engagers\, TIL (tumour-infiltrating lymphocyte) therapy\, and CAR T cells. She’ll explain briefly how they work and why they’re valuable treatments for some patients and not others. \nAudience\nThis content is ideal for research nurses\, clinical nurse specialists\, pharmacists\, and clinical trials coordinators. It may also interest other healthcare professionals wanting to improve their understanding of immunotherapy. \nThis course is ideal for anyone new to cancer immunotherapy and would like to understand how these treatments came about and how they work. \nAs ever\, Elaine will use colourful illustrations and jargon-free explanations to help learners gain a broad understanding of the concepts covered. \nCourse delivery\nThe course comprises a single morning comprising three sessions\, delivered online via Microsoft Teams\, focusing on the following: \n\nSession one: An introduction to cancer and the immune system\nSession two: Immune checkpoint inhibitors\nSession three: Other forms of immunotherapy\n\nDetailed Programme\n9:30am Session 1 – Cancer’s relationship with the immune system  \n•         A brief introduction to the human immune system \n•         How our cells talk to our immune system \n•         Our immune system’s role in protecting us from cancer \n•         How cancer’s relationship with the immune system changes over time \n•         The difference between “cancer friends” and “cancer foes” \n10:30am Session 2 – Immunotherapy with checkpoint inhibitors  \n•         An introduction to T lymphocytes (T cells) \n•         What T cells do and why our body needs to control them \n•         How T cells kill cancer cells and what sometimes stops them \n•         The mechanism of action of immune checkpoint inhibitors such as pembrolizumab\, nivolumab\, and ipilimumab \n11:30am Session 3 – Other forms of immunotherapy  \n•         An overview of different immunotherapy strategies\, such as: \n•         Antibody-based immunotherapies given to people with haematological cancer \n•         T cell engagers: double-ended proteins that connect cancer cells and T cells \n•         Vaccine-based treatments that alert the body to the presence of cancer cells \n•         Using living T cells to treat cancer \n12.30pm – close \nCourse lead\nDr Elaine Vickers PhD of Science Communicated Ltd\nDr Elaine Vickers\, PhD of Science Communicated Ltd has worked as a cancer educator for over twenty years and has previously acted as science communicator for three of the UK’s leading medical research charities\, including four years in the Science Information team at Cancer Research UK. \nElaine is passionate about demystifying the science behind cancer biology and the latest cancer treatments such as kinase inhibitors\, monoclonal antibodies and immunotherapies. \nShe is experienced in teaching people with any level of scientific or medical knowledge from cancer patients through to medical oncologists translating complex and often overwhelming topics into easily digestible and understandable knowledge\, using colourful illustrations to explain scientific concepts. \nThe second edition of her book\, A Beginner’s Guide to Targeted Cancer Treatments – commended by the British Medical Association book awards is due out by the end of 2024. \nBooking\nTo book a place on this course go to Tickets at the bottom of the page. \nAt checkout you can make an online card payment or enter a coupon code to make alternative payment arrangements. \nAlternative payment arrangements include: \n\nrequesting an invoice (INVOICE)\,\nThe Newcastle upon Tyne Hospitals NHS Foundation Trust staff internal funding (NUTH) – you will need to complete a Trust study leave form.\n\nPlease see the Making payments & Coupons sections of the Help and FAQs.
URL:https://skillsacademy.newcastle-hospitals.nhs.uk/course/beginners-guide-to-cancer-immunotherapy-october-2024/
LOCATION:Virtual delivery via MS Teams
ATTACH;FMTTYPE=image/jpeg:https://skillsacademy.newcastle-hospitals.nhs.uk/wp-content/uploads/2023/10/MicrosoftTeams-image-1.jpg
ORGANIZER;CN="Newcastle Hospitals Skills Academy":MAILTO:nuth.newcastlehospitalsskillsacademy@nhs.net
END:VEVENT
END:VCALENDAR